33.18
1.19%
0.3904
전일 마감가:
$32.79
열려 있는:
$32.85
하루 거래량:
125.74K
Relative Volume:
0.19
시가총액:
$1.86B
수익:
$656.11M
순이익/손실:
$114.99M
주가수익비율:
13.49
EPS:
2.46
순현금흐름:
$212.78M
1주 성능:
+0.55%
1개월 성능:
-5.06%
6개월 성능:
+11.91%
1년 성능:
+20.79%
하모니 바이오 Stock (HRMY) Company Profile
명칭
Harmony Biosciences Holdings Inc
전화
(484) 539-9800
주소
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
HRMY | 33.17 | 1.86B | 656.11M | 114.99M | 212.78M | 2.46 |
VRTX | 449.59 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 747.35 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 597.03 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 247.31 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 107.96 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
하모니 바이오 Stock (HRMY) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-06-21 | 개시 | Citigroup | Buy |
2024-01-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2023-09-25 | 다운그레이드 | Goldman | Neutral → Sell |
2023-09-07 | 개시 | Berenberg | Buy |
2023-04-20 | 개시 | BofA Securities | Neutral |
2022-10-14 | 업그레이드 | Janney | Neutral → Buy |
2022-10-14 | 업그레이드 | Jefferies | Hold → Buy |
2022-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
2022-07-13 | 다운그레이드 | Goldman | Buy → Neutral |
2022-07-07 | 개시 | Mizuho | Buy |
2022-04-14 | 개시 | Cantor Fitzgerald | Overweight |
2021-12-01 | 개시 | Oppenheimer | Outperform |
2021-11-04 | 개시 | Raymond James | Outperform |
2021-09-23 | 개시 | Needham | Buy |
2021-03-29 | 업그레이드 | Goldman | Neutral → Buy |
2020-09-14 | 개시 | Goldman | Neutral |
2020-09-14 | 개시 | Jefferies | Buy |
2020-09-14 | 개시 | Piper Sandler | Overweight |
모두보기
하모니 바이오 주식(HRMY)의 최신 뉴스
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES - Lelezard
Harmony Biosciences to Present at Citi and Piper Sandler Healthcare Conferences | HRMY Stock News - StockTitan
Harmony Biosciences Reports Record Revenue and Plans Expansion in CNS Treatments - MSN
HRMY (Harmony Biosciences Holdings) GF Value Rank : 4 (As of Nov. 20, 2024) - GuruFocus.com
Principal Financial Group Inc. Sells 19,654 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Quest Partners LLC Acquires 20,689 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
First Week of July 2025 Options Trading For Harmony Biosciences Holdings (HRMY) - Nasdaq
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Significant Drop in Short Interest - MarketBeat
14,396 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Purchased by CWA Asset Management Group LLC - MarketBeat
Harmony Biosciences’ Common Stock Offering - Global Legal Chronicle
Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Harmony Biosciences director Antonio Gracias sells $139m in stock - Investing.com India
Marshman Fund Trust II sells $139.39 million in Harmony Biosciences stock - Investing.com
Harmony Biosciences director Antonio Gracias sells $139m in stock By Investing.com - Investing.com UK
AlphaCentric Advisors LLC Has $3.88 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings - Yahoo Canada Finance
Top 5 US Stocks To Buy In November 2024 - Investing.com
HRMY vs. REGN: Which Stock Is the Better Value Option? - MSN
(HRMY) Trading Signals - Stock Traders Daily
Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now? - Yahoo Finance
Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat - MSN
Harmony Biosciences Holdings Prices of Public Offering of Common Stock - citybiz
Harmony Biosciences chief commercial officer sells $870,018 in stock - Investing.com India
Harmony Biosciences chief commercial officer sells $870,018 in stock By Investing.com - Investing.com Canada
Latham Advises Harmony Biosciences Holdings, Inc. in Public Offering of Common Stock by Selling Shareholders - Latham & Watkins LLP
HRMY Makes Notable Cross Below Critical Moving Average - Nasdaq
Harmony Biosciences (NASDAQ:HRMY) Sees Strong Trading Volume Following Analyst Upgrade - MarketBeat
Cantor Fitzgerald Issues Positive Estimate for HRMY Earnings - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2024 Earnings Call Transcript - Insider Monkey
Harmony Biosciences Holdings, Inc. Just Recorded A 19% EPS Beat: Here's What Analysts Are Forecasting Next - Simply Wall St
Goldman Sachs maintains sell rating on HRMY stock with $28 target - Investing.com Canada
Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Hi - GuruFocus.com
Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders - StockTitan
Harmony’s Wakix Surpasses $2B in Revenue, Data Shows Promise for IH Treatment - Sleep Review
Goldman Sachs maintains sell rating on HRMY stock with $28 target By Investing.com - Investing.com South Africa
Cantor Fitzgerald Raises Harmony Biosciences (NASDAQ:HRMY) Price Target to $58.00 - MarketBeat
Harmony Biosciences' (HRMY) "Outperform" Rating Reaffirmed at Oppenheimer - MarketBeat
Harmony Biosciences: Strong Q3 and Future Growth - MSN
Harmony Biosciences (NASDAQ:HRMY) Releases Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Shares Gap DownHere's Why - MarketBeat
Is Harmony Biosciences Holdings (NASDAQ:HRMY) Using Too Much Debt? - Simply Wall St
Harmony Biosciences stock hits 52-week high at $40.73 By Investing.com - Investing.com Australia
Axonis Therapeutics Announces $115 Million Series A Financing - Quantisnow
Goldman Sachs Reiterates Sell Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider.com
Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ... - Investing.com Canada
HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUA - GuruFocus.com
Harmony Biosciences initiates public stock offering by shareholders By Investing.com - Investing.com South Africa
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Large Decrease in Short Interest - MarketBeat
하모니 바이오 (HRMY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):